Farallon Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $119M | Buy |
|
|||||
|
2023
Q3 | $43.6M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $42.2M | Sell |
|
|||||
|
2021
Q2 | $145M | Buy |
|
|||||
|
2021
Q1 | $146M | Sell |
|
|||||
|
2020
Q4 | $192M | Hold |
|
|||||
|
2020
Q3 | $145M | Buy |
|
|||||
|
2020
Q2 | $74.2M | Buy |
|
|||||
|
2020
Q1 | $46.1M | Buy |
|
|||||
|
2019
Q4 | $22.6M | Sell |
|
|||||
|
2019
Q3 | $23.4M | Sell |
|
|||||
|
2019
Q2 | $102M | Sell |
|
|||||
|
2019
Q1 | $88M | Sell |
|
|||||
|
2018
Q4 | $55.1M | Buy |
|
|||||
|
2018
Q3 | $41.2M | Buy |
|
|||||
|
2018
Q2 | $36.7M | Buy |
|
|||||
|
2018
Q1 | $8.29M | Buy |
|